Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Salgia, Ravi

One or more keywords matched the following items that are connected to Salgia, Ravi

Item Type	Name
Concept	Protein Kinase C-delta
Concept	Mitogen-Activated Protein Kinase 3
Concept	Mitogen-Activated Protein Kinase Kinases
Concept	Protein Kinase C
Concept	CDC2 Protein Kinase
Concept	Mitogen-Activated Protein Kinase 1
Concept	Protein Kinase C-alpha
Concept	Protein Kinase Inhibitors
Academic Article	Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Academic Article	Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells.
Academic Article	Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.
Academic Article	Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.
Academic Article	c-Met inhibition.
Academic Article	Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Academic Article	Protein kinase C beta in malignant pleural mesothelioma.
Academic Article	EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article	The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article	Role of c-Met in cancer: emphasis on lung cancer.
Academic Article	Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
Academic Article	Fyn: a novel molecular target in cancer.
Academic Article	Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.
Academic Article	Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.
Academic Article	Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Academic Article	Role of protein kinase C ß and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Academic Article	MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
Academic Article	c-Met is a potentially new therapeutic target for treatment of human melanoma.
Academic Article	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Academic Article	Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Academic Article	Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Academic Article	Novel targets for therapeutic agents in small cell lung cancer.
Academic Article	The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Academic Article	RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Academic Article	Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Academic Article	The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article	Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.
Academic Article	Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article	Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.
Academic Article	A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
Academic Article	Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Academic Article	Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Academic Article	Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Academic Article	Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Academic Article	FAK and paxillin, two potential targets in pancreatic cancer.
Academic Article	Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article	Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article	PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Academic Article	Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Academic Article	TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Academic Article	MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
Academic Article	Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Academic Article	Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
Academic Article	Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article	Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
Academic Article	Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.
Academic Article	The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Academic Article	MET receptor in oncology: From biomarker to therapeutic target.
Academic Article	Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer.
Academic Article	Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report.
Academic Article	Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.
Academic Article	Activating p53 function by targeting RLIP.
Academic Article	Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor.
Concept	Protein Kinase C beta
Academic Article	Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer.
Academic Article	Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.

Search Criteria

Cyclic AMP Dependent Protein Kinases